Brief: WuXi Biologics Posts H1 Gross Profit RMB3,350 Million
21/08/2024 13:08
Aug 21 (Reuters) - WuXi Biologics H1 gross profit RMB 3,350 million. * H1 gross margin 39.1% * H1 revenue RMB 8,574.2 million * H1 net income RMB 1,780.3 million * H1 adjusted net income RMB 2,250.3 million
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln